Ozone therapy prevents renal inflammation and fibrosis in a rat model of acute pyelonephritis

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 71, Issue 6, 2011, Pages 473-480

  Caliskan, Bahadir ^a   Guven, Ahmet ^a   Ozler, Mehmet ^a   Cayci, Tuncer ^a   Ozcan, Ayhan ^a   Bedir, Orhan ^a   Surer, Ilhami ^a   Korkmaz, Ahmet ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

fibrosis; Kidney; oxidative stress; ozone; pyelonephritis

Indexed keywords

CIPROFLOXACIN; CREATININE; GLUTATHIONE PEROXIDASE; NEOPTERIN; PROCALCITONIN; SUPEROXIDE DISMUTASE; UREA;

ACUTE PYELONEPHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; ESCHERICHIA COLI; HISTOPATHOLOGY; KIDNEY; KIDNEY FIBROSIS; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; OZONE THERAPY; PRIORITY JOURNAL; RAT; TREATMENT DURATION; TUBULAR DYSFUNCTION; UREA BLOOD LEVEL;

ACUTE DISEASE; ANIMALS; ANTI-BACTERIAL AGENTS; ASPARTATE AMINOTRANSFERASES; CALCITONIN; CIPROFLOXACIN; CREATINE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ESCHERICHIA COLI INFECTIONS; FIBROSIS; GLUTATHIONE PEROXIDASE; KIDNEY; L-LACTATE DEHYDROGENASE; MALE; MALONDIALDEHYDE; NEOPTERIN; OXIDATIVE STRESS; OZONE; PROTEIN PRECURSORS; PYELONEPHRITIS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; UREA;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; RATTUS;

EID: 80052944619     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2011.587022     Document Type: Article

References (48)

1. Pavlova EL, Lilova MI, Savov VM. Oxidative stress in children with kidney disease. Pediatr Nephrol 2005;20: 1599-604. (Pubitemid 41554473)
2. Mundi H, Bjorksten B, Svanborg C, Ohman L, Dahlgren C. Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring. Infect Immun 1991;59:4168-72.
3. Biyikli NK, Tugtepe H, Sener G, Velioglu-Ogunc A, Cetinel S, Midillioglu S, Gedik N, Yegen BC. Oxytocin alleviates oxidative renal injury in pyelonephritic rats via a neutrophil-dependent mechanism. Peptides 2006;27: 2249-57. (Pubitemid 44189625)
4. Webb NJ,Brenchley PE. Cytokines and cell adhesion molecules in the Inflammatory response during acute pyelonephritis. Nephron Exp Nephrol 2004;96:e1-6.
5. Roberts JA. Mechanisms of renal damage in chronic pyelonephritis (refl ux nephropathy). Curr Top Pathol 1995; 88:265-87.
6. Gupta A, Sharma S, Nain CK, Sharma BK, Ganguly NK. Reactive oxygen species-mediated tissue injury in experimental ascending pyelonephritis. Kidney Int 1996;49:26-33. (Pubitemid 26022824)
7. Oh-oka H, Fujisawa M, Okada H, Arakawa S, Kamidono S. Differential involvement of reactive oxygen species and myeloperoxidase in oxygen-dependent killing of urinary tract bacterial isolates by polymorphonuclear leukocytes. Urol Res 2001;29:423-7. (Pubitemid 34042190)
8. Mittal R, Sharma S, Chhibber S, Harjai K. Contribution of free radicals to Pseudomonas aeruginosa induced acute pyelonephritis. Microb Pathog 2008;45:323-30. (Pubitemid 50276730)
9. Bocci V. Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediators Inflamm 2004; 13:3-11. (Pubitemid 38621643)
10. Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res 2006;37:425-35.
11. Souza YM, Fontes B, Martins JO, Sannomiya P, Brito GS, Younes RN, Rasslan S. Evaluation of the effects of ozone therapy in the treatment of intra-abdominal infection in rats. Clinics (Sao Paulo) 2010;65:195-202.
12. Re L, Mawsouf MN, Menendez S, Leon OS, Sanchez GM, Hernandez F. Ozone therapy: clinical and basic evidence of its therapeutic potential. Arch Med Res 2008;39:17-26. (Pubitemid 350192013)
13. Oter S,Korkmaz A. Relevance of hyperbaric oxygen to ozone therapy. Arch Med Res 2006;37:917-8.
14. Bocci V, Zanardi I, Travagli V. Has oxygen-ozone therapy a future in medicine? J Exp Integr Med 2011;1:5-11.
15. Ajamieh H, Merino N, Candelario-Jalil E, Menendez S, Martinez-Sanchez G, Re L, Giuliani A, Leon OS. Similar protective effect of ischaemic and ozone oxidative preconditionings in liver ischaemia/reperfusion injury. Pharmacol Res 2002;45:333-9. (Pubitemid 35430529)
16. Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, Chen Z. Similarities between ozone oxidative preconditioning and ischemic preconditioning in renal ischemia/reperfusion injury. Arch Med Res 2008;39:169-78. (Pubitemid 350299621)
17. Uysal B, Yasar M, Ersoz N, Coskun O, Kilic A, Cayc T, Kurt B, Oter S, Korkmaz A, Guven A. Effi cacy of hyperbaric oxygen therapy and medical ozone therapy in experimental acute necrotizing pancreatitis. Pancreas 2010;39:9-15.
18. Guven A, Gundogdu G, Sadir S, Topal T, Erdogan E, Korkmaz A, Surer I, Ozturk H. The effi cacy of ozone therapy in experimental caustic esophageal burn. J Pediatr Surg 2008;43:1679-84.
19. Guven A, Gundogdu G, Vurucu S, Uysal B, Oztas E, Ozturk H, Korkmaz A. Medical ozone therapy reduces oxidative stress and intestinal damage in an experimental model of necrotizing enterocolitis in neonatal rats. J Pediatr Surg 2009;44:1730-5.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
21. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8. (Pubitemid 9194347)
22. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modifi ed proteins. Methods Enzymol 1990;186:464-78. (Pubitemid 20279989)
23. Durak I, Yurtarslanl Z, Canbolat O, Akyol O. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin Chim Acta 1993;214:103-4. (Pubitemid 23055374)
24. Paglia DE,Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-69.
25. Chatterjee PK, Patel NS, Kvale EO, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Thiemermann C. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 2002;61:862-71. (Pubitemid 34175453)
26. Alrashed M, Abougoush M, Akgul EO, Erbil MK. Detection method of serum and urine neopterin levels by high performance liquid chromatography. Gulhane MJ 2002;44:273-7.
27. Pecile P, Miorin E, Romanello C, Falleti E, Valent F, Giacomuzzi F, Tenore A. Procalcitonin: a marker of severity of acute pyelonephritis among children. Pediatrics 2004; 114:e249-54.
28. Fuchs D, Weiss G, Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol 1993;101:1-6. (Pubitemid 23179069)
29. Couser WG. Pathogenesis of glomerular damage in glomerulonephritis. Nephrol Dial Transplant 1998;13 (Suppl. 1):10-5. (Pubitemid 28059573)
30. Hosseini F, Naseri MK, Badavi M, Ghaffari MA, Shahbazian H, Rashidi I. Effect of beta carotene on lipid peroxidation and antioxidant status following renal ischemia/reperfusion injury in rat. Scand J Clin Lab Invest 2010;70:259-63.
31. Gupta R, Verma I, Sharma S, Ganguly NK. Prevention of tissue injury in an ascending mouse model of chronic pyelonephritis - role of free radical scavengers. Comp Immunol Microbiol Infect Dis 2004;27:225-34. (Pubitemid 38724181)
32. Imamoglu M, Cay A, Cobanoglu U, Bahat E, Karahan C, Tosun I, Sarihan H. Effects of melatonin on suppression of renal scarring in experimental model of pyelonephritis. Urology 2006;67:1315-9. (Pubitemid 43818065)
33. Kavukcu S, Soylu A, Turkmen M, Sarioglu S, Buyukgebiz B, Gure A. The role of vitamin A in preventing renal scarring secondary to pyelonephritis. BJU Int 1999;83:1055-9. (Pubitemid 29271879)
34. Yagmurlu A, Boleken ME, Ertoy D, Ozsan M, Gokcora IH, Dindar H. Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis. Urology 2003;61:1037-41. (Pubitemid 36547766)
35. Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev 2009;29:646-82.
36. Halliwell B, Clement MV, Long LH. Hydrogen peroxide in the human body. FEBS Lett 2000;486:10-3.
37. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 2002;3:1129-34. (Pubitemid 35469696)
38. Z amora ZB, Borrego A, Lopez OY, Delgado R, Gonzalez R, Menendez S, Hernandez F, Schulz S. Effects of ozone oxidative preconditioning on TNF-alpha release and antioxidantprooxidant intracellular balance in mice during endotoxic shock. Mediators Inflamm 2005;2005:16-22. (Pubitemid 40942906)
39. Madej P, Plewka A, Madej JA, Nowak M, Plewka D, Franik G, Golka D. Ozonotherapy in an induced septic shock. I. Effect of ozonotherapy on rat organs in evaluation of free radical reactions and selected enzymatic systems. Inflammation 2007;30:52-8. (Pubitemid 46438048)
40. Bette M, Nusing RM, Mutters R, Zamora ZB, Menendez S, Schulz S. Effi ciency of tazobactam/piperacillin in lethal peritonitis is enhanced after preconditioning of rats with O3/O2-pneumoperitoneum. Shock 2006;25:23-9.
41. Calunga JL, Zamora ZB, Borrego A, Rio S, Barber E, Menendez S, Hernandez F, Montero T, Taboada D. Ozone therapy on rats submitted to subtotal nephrectomy: role of antioxidant system. Mediators Inflamm 2005;2005:221-7. (Pubitemid 41381513)
42. Clavo B, Catala L, Perez JL, Rodriguez V, Robaina F. Ozone therapy on cerebral blood flow: a preliminary report. Evid Based Complement Alternat Med 2004;1:315-9.
43. Di Paolo N, Bocci V, Cappelletti F, Petrini G, Gaggiotti E. Necrotizing fasciitis successfully treated with extracorporeal blood oxygenation and ozonization (EBOO). Int J Artif Organs 2002;25:1194-8. (Pubitemid 36104353)
44. Peralta C, Xaus C, Bartrons R, Leon OS, Gelpi E, Rosello-Catafau J. Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion. Free Radic Res 2000;33:595-605. (Pubitemid 32103700)
45. Altinel O, Demirbas S, Cakir E, Yaman H, Ozerhan IH, Duran E, Cayci T, Akgul EO, Ersoz N, Uysal B, Kurt B, Yasar M, Oter S, Peker Y. Comparison of hyperbaric oxygen and medical ozone therapies in a rat model of experimental distal colitis. Scand J Clin Lab Invest 2011;71:185-92.
46. Bocci V, Valacchi G, Corradeschi F, Aldinucci C, Silvestri S, Paccagnini E, Gerli R. Studies on the biological effects of ozone: 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone. J Biol Regul Homeost Agents 1998;12:67-75. (Pubitemid 28470072)
47. Ohtsuka H, Ogata A, Terasaki N, Koiwa M, Kawamura S. Changes in leukocyte population after ozonated autohemoadministration in cows with Inflammatory diseases. J Vet Med Sci 2006;68:175-8. (Pubitemid 43345921)
48. Benador N, Siegrist CA, Gendrel D, Greder C, Benador D, Assicot M, Bohuon C, Girardin E. Procalcitonin is a marker of severity of renal lesions in pyelonephritis. Pediatrics 1998;102:1422-5. (Pubitemid 28550836)